NEW YORK (GenomeWeb) – Bio-Techne this week reported that its revenue for the second quarter rose 17 percent year over year to $154.2 million from $131.8 million, exceeding the average analyst estimate of $146.3 million.

Revenues from the firm's diagnostics business segment fell 4 percent to $23.4 million from $24.3 million in the prior-year quarter. Sales volume in the quarter was negatively affected by continued "push-outs” of orders by original equipment manufacturers "in a very cost-conscious diagnostics industry," the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.